The Future of SARS-CoV-2 Vaccination
N Engl J Med
.
2022 Mar 3;386(9):899.
doi: 10.1056/NEJMc2119437.
Authors
Martin F Bachmann
1
,
Mona O Mohsen
1
,
Daniel E Speiser
1
Affiliation
1
University Hospital Bern, Bern, Switzerland doc@dspeiser.ch.
PMID:
35235737
DOI:
10.1056/NEJMc2119437
No abstract available
Publication types
Letter
Comment
MeSH terms
Antibodies, Viral
COVID-19 Vaccines
COVID-19* / prevention & control
Humans
SARS-CoV-2*
Vaccination
Substances
Antibodies, Viral
COVID-19 Vaccines